Abstract

Preventive Treatment of Migraine: Which Drugs to Choose. Own Experience

Migraine prophylaxis is a demonstrated viable therapeutic option, providing positive results through the use of drugs, more and more safe and effective. These drugs are anticonvulsant, antidepressant, calcium channel blockers, beta blockers, making a notable contribution according to studies reported in the literature. But they also have side effects, usually less than their efficacy. In this study we report our series of migraineurs with and without aura, treated with prophylactic drugs. In the study we used the drugs of first choice and we used VAS scale to assess pain intensity, checking patients for 8 months, with good results, in some cases excellent. Data from literature show that these new nutraceutical substances, besides to those already in use, are utilized successfully, opening new therapeutic perspectives. Do not resort to symptomatic drugs, it is very important, being rich in adverse, potentially harmful effects, so migraine prophylaxis remains a useful instrument of defense in these patients.


Author(s):

Domenico Chirchiglia, Attilio Della Torre, Carmelino Angelo Stroscio and Angelo Lavano



Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+

Recommended Conferences

  • 4th Global Experts Meeting on Parkinson’s & Movement Disorders, Singapore
    May 14-15, Singapore
  • 10th World Congress on Alzheimers Disease & Dementia
    May 30-31, 2018 Osaka, Japan
  • 3rd International Conference on Spine and Spinal Disorders
    June 11-12, London, UK
Flyer image

Abstracted/Indexed in

  • Google Scholar
  • Directory of Research Journal Indexing (DRJI)
  • WorldCat